Quetta Acquisition Corp. — Form 10-Q Summary
Reporting period: Quarter ended September 30, 2023. Quetta is a newly formed blank-check company seeking a business combination, with an intended focus on financial technology businesses in Asia, excluding China, Hong Kong, and Macau. It had not commenced operations by quarter-end.
Financial results and position
- Revenue: None reported; the company had no operating revenue. Its only income was interest income.
- Net income: $2,949 for the three months ended September 30 and $3,686 from inception on May 1 through September 30. The statement reports $0.00 basic and diluted earnings per share.
- Cash flow: Inception-to-date operating cash flow was $3,686; financing cash flow was $258,972; ending cash was $262,658. There were no investing cash flows reported.
- Assets and liquidity: Total assets were $413,946, including $262,658 cash and $151,288 deferred offering costs. Current liabilities were $385,260; working capital deficit, excluding deferred offering costs, was $122,602.
- Debt and related-party balances: At September 30, the company owed its sponsor $300,000 under an unsecured, interest-free promissory note and $85,000 for offering-related costs. Both balances were repaid October 11, 2023. No working-capital loans were outstanding at quarter-end.
- Margins: Not meaningful; the company had no operating revenue or operating activity.
Material developments and period comparison
- The balance sheet compares September 30 with May 31, 2023. Cash declined from $314,700 to $262,658, while total assets rose from $410,000 to $413,946. Retained earnings increased from zero to $3,686. The filing does not provide a prior-year comparable operating period; the company was formed in May 2023.
- After quarter-end, on October 11, 2023, the company completed its IPO of 6,900,000 units at $10 each, raising $69 million gross, and sold 253,045 private-placement units for $2,530,450. It placed $69,690,000 in trust and reported $774,668 in cash outside the trust after the IPO.
- The underwriters received a 2% cash discount ($1,380,000), and a further $2,415,000 deferred fee is payable from trust funds upon a business combination. The company also issued 69,000 representative shares to the underwriters.
- Full exercise of the over-allotment option means the 225,000 founder shares previously subject to forfeiture are no longer subject to forfeiture.
Outlook, risks, and other matters
- Management expects substantial public-company and transaction-search costs and does not expect operating revenue until after a business combination. No specific target, transaction, or financial guidance is disclosed.
- Management concluded that substantial doubt exists about the company’s ability to continue as a going concern, citing liquidity needs, ongoing costs, and the risk of failing to complete a business combination within the permitted period. The financial statements include no adjustments for the uncertainty.
- The company generally has nine months after the IPO to complete a business combination, with two possible three-month extensions funded by sponsor deposits. If it does not complete a transaction within the applicable period, it must redeem public shares and liquidate, subject to applicable requirements.
- Public shareholders may redeem shares in connection with a business combination. Rights convert into shares only upon a completed combination and may expire worthless if no combination occurs. The company notes that the potential U.S. stock-repurchase excise tax could reduce funds available for a transaction.
- Management cited uncertainty from the war in Ukraine and related sanctions as potentially affecting a transaction or financing. The sponsor’s trust-account indemnity has stated limitations, including exceptions for certain claims.
- Management said disclosure controls were effective at a reasonable-assurance level as of September 30, 2023; no material change in internal control over financial reporting was reported. No legal proceedings were disclosed.
Important facts to verify
- Confirm the reporting date: the balance-sheet heading in the supplied filing text says “September 31,” while the statements and filing period identify September 30.
- Confirm IPO timing: the notes and subsequent-events disclosures say October 11, 2023, but the MD&A contains a conflicting reference to October 11, 2022.
- Confirm presentation of earnings per share: the statements report positive net income but label the per-share measure “net loss per share.”
- Review post-IPO trust and outside-trust cash balances, deferred underwriting fees, and ongoing sponsor-related expenses when assessing liquidity and transaction capacity.
- Track the business-combination deadline, any funded extensions, redemption levels, and the company’s ability to complete a transaction before liquidation.